Cytokines induce thymidine phosphorylase expression in tumor cells and make them more susceptible to 5′-deoxy-5-fluorouridine Hiroyuki EdaKaori FujimotoHideo Ishitsuka Original Articles Pages: 333 - 338
Synergistic enhancement by interleukin-1 α of cisplatin-mediated antitumor activity in RIF-1 tumor-bearing C3H/HeJ mice Candace S. JohnsonMing-Jei ChangPhilip Furmanski Original Articles Pages: 339 - 346
Five-day infusional fluorodeoxyuridine with oral leucovorin and escalating doses of interferon alpha-2b: a phase I study Everett E. VokesSheila M. O'BrienMark J. Ratain Original Articles Pages: 347 - 352
Effect of toremifene on the growth, hormone receptors and insulin-like growth factor-1 of hormone-dependent MCF-7 tumors in athymic mice Yuchi IinoYoshiki TakaiYasuo Morishita Original Articles Pages: 353 - 358
Advanced breast cancer treatment with folinic acid, 5-fluorouracil, and mitomycin C G. FranciniR. PetrioliS. Gonnelli Original Articles Pages: 359 - 364
Extravasation injury potential of CI-980 a novel synthetic mitotic inhibitor John R. MacDonaldDavid G. Pegg Original Articles Pages: 365 - 367
Human autopsy tissue distribution of the epipodophyllotoxins etoposide and teniposide David J. StewartDarshan GrewaalRobert M. Green Original Articles Pages: 368 - 372
Human autopsy-tissue distribution of menogaril and its metabolites David J. StewartDarshan GrewaalRobert Earhart Original Articles Pages: 373 - 378
Cellular pharmacokinetics of doxorubicin in patients with chronic lymphocytic leukemia: comparison of bolus administration and continuous infusion Catherine MullerEtienne ChatelutGuy Laurent Original Articles Pages: 379 - 384
Detection of Adriamycin-induced cardiotoxicity in cultured heart cells with technetium 99m-SESTAMIBI David Piwnica-WormsMary L. ChiuJames F. Kronauge Original Articles Pages: 385 - 391
Topical toremifene: a new approach for cutaneous melanoma? Juhani MaenpaaThomas DooleyMichael DeGregorio Original Articles Pages: 392 - 395
Tamoxifen stimulates in vivo growth of drug-resistant estrogen receptor-negative breast cancer Juhani MaenpaaValerie WiebeMichael DeGregorio Short Communication Pages: 396 - 398
Phase II study of 4′-iodo-4′-deoxydoxorubicin in non-resectable non-small-cell lung cancer Jens Benn SørensenLars StenbygaardHeine H. Hansen Short Communication Pages: 399 - 402
Postoperative chemotherapy without radiation in young children with malignant non-astrocytic brain tumours Les WhiteHeather JohnstonIan Toogood Short Communication Pages: 403 - 406
Pulmonary toxicity in patients with non-Hodgkin's lymphoma treated with bleomycin-containing combination chemotherapy H. Y. S. NganRaymond H. S. LiangT. K. Chan Short Communication Pages: 407 - 409
